Sponsor:
Institute for Clinical Research
Code:
NCT00210301
Conditions
Relapsing-Remitting Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 20 - 65
Healthy Volunteers: Not accepted
Interventions
Provigil (modafinil)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Institute for Clinical Research on 2006-09-07.